Intaleaf (part of Nompharma Limited) is a wholesale distributor of CBPMs supplying licensed pharmacies, hospitals and wholesalers.
We work with GMP-compliant manufacturers and licensed distributors in the UK, EU and internationally, operating in line with MHRA WDA(H) and Good Distribution Practice (GDP).
International movements are performed only under the appropriate Home Office licences and applicable destination-country requirements.
We do not supply the public and we do not provide medical advice.
At Intaleaf, we are guided by reliability, transparency, and product safety in everything we do.
We uphold the highest standards of integrity, ensuring full traceability and regulatory compliance across all operations.
Our commitment to quality and collaboration drives us to build global partnerships that support reliable, compliant CBPM supply for licensed organisations
We use audited logistics partners and secure storage with procedures proportionate to controlled drug requirements. Our approach includes:
To protect the supply chain, we complete bona fide checks before onboarding any customer or supplier.
Typical information we review includes:
Orders are supplied only to verified, licensed organisations and in accordance with the scope of authorisations held by all parties.
Intaleaf adheres to anti-bribery and corruption policies and maintains robust data protection practices. We aim for clear documentation, accurate statements, and consistent communication with stakeholders.
Our GDP-aligned quality system covers:
These measures help ensure that products are stored, transported and documented in line with regulatory expectations.
We work with licensed producers and distributors that meet GMP/GDP expectations. Collaboration is focused on:
